Caristix Named to Top 25 Up and Comers List
April 24, 2012
We’re happy to announce that Caristix has made the list of Top 25 Up and Comers among Canadian ICT companies. Check out the Top 25
We’re happy to announce that Caristix has made the list of Top 25 Up and Comers among Canadian ICT companies. Check out the Top 25
Caristix was selected to present at Interconnected Health 2012 recently, and we focused on a new concept, HL7 Interface Lifecycle Management. Up till now, there’s
Implementing systems doesn’t mean much these days if they remain data islands unto themselves, but far too many teams rely on the drawn-out iterative processes
If you’re going to be at Interconnected Health 2012 (April 2-4) in Chicago, check out the session with Jean-Luc Morin, VP R&D here at Caristix.
One of the things we realized when we formed Caristix is that the biggest pitfall in HL7 interfacing isn’t coding or setting up the interface.
Typically, when you start an interfacing project, there’s a getting-your-feet-wet stage. “Where’s the MRN in that feed? Does it have leading zeros? Who’s got the
One of our Cloak customers is de-identifying close to 14 GB of clinical data coming from several healthcare information systems (including 2 ADTs and a
One of our Cloak customers is de-identifying several GB of clinical data coming from several healthcare information systems (including 2 ADTs and a lab system)
Healthcare IT blog HIStalk featured Caristix in a series on innovative companies developing technology products for hospitals, providers, and others in healthcare. Here’s what one
HL7: What You Don’t Know Can Hurt You How many times do hospital IS/IT directors come across this scenario? Your hospital has just signed on
NORTH AMERICA: +1 (877)-872-0027
WORLD: 1-418-872-4000
EMAIL: info@caristix.com
ASIA-PACIFIC
DENIS CANTIN
T: +61418441388
denis.cantin@caristix.com
NORTH AMERICA & EUROPE
JEAN-LUC MORIN
T: 418 872-4000
jeanluc.morin@caristix.com
HL7® / FHIR® are a registered trademarks of Health Level Seven International. The use of this trademark does not constitute an endorsement by HL7.